최근 발병한 정신분열병 환자의 증상 관해 및 정신사회적 기능 : 1년 전향적 추적 관찰 연구

키워드

참고문헌 (43)

1. Gupta S, "The Iowa Longitudinal Study of Recent Onset Psychosis: one-year folow-up of first episode patients", 23, pp.1~13 (1997)
2. Robinson DG, "Predictors of treatment response from a first episode of schizo-phrenia or schizoafective disorder", 156, pp.544~549 (1999)
3. Lieberman JA, "Effectivenes of antipsychotic drugs in patients with chronic schizophrenia", 353, pp.1209~1223 (2005)
4. Larsen TK, "Premorbid func-tioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis", 45, pp.1~9 (2000)
5. Ucok A, "One year outcome in first episode schizophrenia. Predictors of relapse", 256, pp.37~43 (2006)
6. Mala AK, "One year outcome in first episode psychosis: in-fluence of DUP and other predictors", 54, pp.231~242 (2002)
7. Andreasen NC, "Remision in schizophrenia: proposed criteria and rationale for consensus", 162, pp.441~449 (2005)
8. Robinson DG, "Symptomatic and functional recovery from a first episode of schizophrenia or schizoafective disorder", 161, pp.473~479 (2004)
9. Ho BC, "Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life", 155, pp.1196~1201 (1998)
10. Tohen M, "The McLean-Harvard first-episode project: 6-month symptoma-tic and functional outcome in afective and nonafective psychosis", 48, pp.467~476 (2000)
11. Hopper K, "Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia", 26, pp.835~846 (2000)
12. Sartorius N, "Shapiro R. Cross-cultural diferences in the short-term prognosis of schizophrenic psychoses. Schizophr Bul 1978", pp.102~13
13. Ran M, "Natural course of schizophrenia: 2-year folow-up study in a rural Chinese community", 178, pp.154~158 (2001)
14. Kua J, "A 20-year folow-up study on schizophrenia in Singapore", 108, pp.18~125 (2003)
15. Kurihara T, "Outcome of schizophrenia in a non-industrialized society: comparative study betwen Bali and Tokyo", 101, pp.148~152 (2000)
16. Choi JW, "Quality of life in the first admited schizophrenic patients: a retrospective folow-up study", 36, pp.987~996 (1997)
17. Kim YS, "Lee JK. 5-year folow-up study of schizophrenia. J Korean Neuropsychiatr Asoc 1987", pp.702~715
18. Lim HS, "The impact of untreated psycho-sis on clinical outcome in first-episode schizophrenia: retrospective study", 7, pp.9~14 (2004)
19. Jung JC, "Long-term outcomes of patients with first-episode schizophrenia spectrum disorder and efects of duration of untreated psychosis in them", 8, pp.64~73 (2005)
20. Dosenbach M, "Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month folow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study", 66, pp.1021~1030 (2005)
21. Andreasen NC, "Arndt S. The Comprehensive Asesment of Symptoms and History . An instrument for assessing diag-nosis and psychopathology. Arch Gen Psychiatry 1992", pp.615~623
22. Andreasen N. Psychiatric Status You Curently Have-Baseline Version, "The University of Iowa" (1989)
23. Song W, "et al. The Korean version of Heinrichs Quality of Life Scale", pp.86~97
24. Cliford PI, "Measuring disability and outcomes in routine practice with the FACE Core Asesment", 63, pp.32~345 (1999)
25. Jackson HJ, "Prodromal symptoms of schi-zophrenia in first-episode psychosis: prevalence and specificity", 36, pp.241~250 (1995)
26. Dawson ME, "Schel AM. Electrodermal anomalies in recent-onset schizophrenia relationships to symptoms and progno-sis. Schizophr Bul 1992", pp.295~311
27. Beasley CM Jr, "A double-blind, randomized, placebo-controled trial of olanzapine in the prevention of psychotic relapse", 23, pp.582~594 (2003)
28. Breier A, "Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and pre-dictors of outcome. Arch Gen Psychiatry 1991", pp.239~246
29. Fenton WS, "McGlashan TH. Natural history of schizophrenia subtypes. I. Positive and negative symptoms and long-term course. Arch Gen Psychiatry 1991", pp.978~986
30. Breier A, "The psychosis of schizophrenia: prevalence, res-ponse to atypical antipsychotics, and prediction of outcome", 46, pp.361~364 (1999)
31. Montes JM, "Safety, effectiveness, and quality of life of olanzapine in first-episode schizophrenia: a naturalis-tic study", 27, pp.667~674 (2003)
32. Crespo-Facoro B, "A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treat-ment of first-episode nonafective psychosis" (2006)
33. Robinson DG, "Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes", 163, pp.2096~2102 (2006)
34. Birchwood M, "Caris M. The influence of ethnicity and family structure on relapse in first-episode schizophrenia. A comparison of Asian", pp.783~790, Macmillan F
35. Barnes TR, "West London first-episode study of schizophrenia. Clinical core-lates of duration of untreated psychosis", 177, pp.207~221 (2000)
36. Byrne M, "Family history of psychiatric disorders and age at first contact in schizophrenia: an epidemiological study", 43, pp.s19~s25 (2002)
37. Gren MF, "Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the right stuf?", 26, pp.19~136 (2000)
38. Douglas MS, "Morison RL. Asesment of enduring deficit and negative symptom subtypes in schizophrenia. Schizophr Bul 1991", pp.565~582
39. Gourevitch R, "Quality of life in schizophrenics with and without the deficit syndrome", 19, pp.172~174 (2004)
40. Bow-Thomas CC, "Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization", 86, pp.131~142 (1999)
41. Voruganti L, "Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability", 28, pp.165~172 (1998)
42. Moos RH, "Global Assessment of Functioning ratings and the allocation and outcomes of mental health services", 53, pp.730~737 (2002)
43. Greenberg GA, "Using the GAF as a national mental health outcome measure in the Department of Veterans Affairs", 56, pp.420~426 (2005)

관련 논문AI추천